Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
18.5M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
723K
-
Shares change
-
+723K
-
Total reported value, excl. options
-
$5.26M
-
Value change
-
+$5.26M
-
Number of buys
-
26
-
Price
-
$7.27
Significant Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) as of Q1 2023
28 filings reported holding CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share as of Q1 2023.
Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 723K shares
of 18.5M outstanding shares and own 3.9% of the company stock.
Largest 10 shareholders include Ikarian Capital, LLC (192K shares), VANGUARD GROUP INC (179K shares), Sio Capital Management, LLC (150K shares), BlackRock Inc. (72.2K shares), BOOTHBAY FUND MANAGEMENT, LLC (38K shares), GEODE CAPITAL MANAGEMENT, LLC (32.9K shares), DIMENSIONAL FUND ADVISORS LP (13.7K shares), STATE STREET CORP (13.2K shares), Virtu Financial LLC (10.1K shares), and Tekla Capital Management LLC (5.14K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.